Clinical trial
Effect of Cabergoline on Weight and Glucose Tolerance
NCT01395602
Study timeline
Study start (unknown)2002-04-01Date precision: month
Registry last updated2015-10-14
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Body Weightunresolved
Impaired Glucose Tolerance in Obeseunresolved
Interventions
CabergolineDRUG · verified · RxNorm: cabergoline
placeboOTHER
Sponsors & collaborators
Columbia Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01395602 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.